HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
Clinical trial NCT02836548 · COMPLETED
Trial details
- NCT number
- NCT02836548
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2023-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.